Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Gains from Investment Securities (2018 - 2025)

BioNexus Gene Lab's Gains from Investment Securities history spans 7 years, with the latest figure at -$23887.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at -$23887.0 for Q4 2025, down 104.49% from a year ago — trailing twelve months through Dec 2025 was -$14823.0 (down 103.01% YoY), and the annual figure for FY2025 was -$14823.0, down 103.01%.
  • Gains from Investment Securities for Q4 2025 was -$23887.0 at BioNexus Gene Lab, down from $21578.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $610213.0 in Q4 2021 to a low of -$466132.0 in Q3 2021.
  • The 5-year median for Gains from Investment Securities is -$4924.0 (2025), against an average of $70265.4.
  • Peak annual rise in Gains from Investment Securities hit 10982.69% in 2021, while the deepest fall reached 7453.59% in 2021.
  • Year by year, Gains from Investment Securities stood at $610213.0 in 2021, then crashed by 148.19% to -$294046.0 in 2022, then soared by 274.03% to $511740.0 in 2023, then rose by 4.07% to $532574.0 in 2024, then plummeted by 104.49% to -$23887.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$23887.0, $21578.0, and -$7590.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.